Study of umbilical cord blood to treat traumatic brain injury

Traumatic brain injury is the primary cause of pediatric trauma related morbidity and mortality. Currently there is no reparative therapeutic option available, and all interventions are designed to prevent injury progression or secondary brain injury.

The current study proposes a Phase 1 Safety Trial using stored autologous Umbilical Cord Blood to treat patients that sustain a severe or moderate TBI, and have not fully recovered as measured by the Glasgow Outcome Score-Expanded/Child at 6 to 18 months post-injury.

Read more about this study on ClinicalTrials.gov